The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution
Abstract
To develop a nano-sized drug delivery system for cancer therapy, amphiphilic hyaluronic acid conjugates were synthesized by chemical conjugation of hydrophobic 5β-cholanic acid to the backbone of hyaluronic acid (HA). The HA conjugates could form nano-sized self-aggregates under physiological conditions (PBS, pH = 7.4, 37 °C) via the hydrophobic interaction among 5β-cholanic acids. The HA nanoparticles were spherical in shape and their sizes were in the range of 350–400 nm, depending on the degree of substitution of 5β-cholanic acid. From a cellular experiment using Cy5.5-labeled HA nanoparticles, it was demonstrated that they are efficiently taken up by SCC7 cancer cells which over-express CD44, the receptor for HA. When the Cy5.5-labeled HA nanoparticles were systemically administrated into the tail vein of tumor-bearing mice, most of the nanoparticles were found in tumor and liver sites. In particular, the fluorescence intensity of nanoparticles at the tumor site was 4-fold higher than that of pure HA polymer, which was confirmed by a non-invasive near-infrared fluorescence imaging system. The high tumor targeting ability of HA nanoparticles might result from both their prolonged circulation in blood and high affinity to tumor cells. These results reveal the promising potential of HA nanoparticles as a stable and effective nano-sized drug delivery system for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Harada, A., & Kataoka, K. (1995) · Macromolecules · doi:10.1021/ma00119a019 · Cited by 848
Hyaluronan: Preparation, Structure, Properties, and Applications
Lapčík, L., Lapčík, L., De Smedt, S., Demeester, J., & Chabreček, P. (1998) · Chemical Reviews · doi:10.1021/cr941199z · Cited by 737
Gerecht, S., Burdick, J. A., Ferreira, L. S., Townsend, S. A., Langer, R., & Vunjak-Novakovic, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703723104 · Cited by 664
Bulpitt, P., & Aeschlimann, D. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199911)47:2<152::aid-jbm5>3.0.co;2-i · Cited by 560
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 490
Min, K. H., Park, K., Kim, Y.-S., Bae, S. M., Lee, S., Jo, H. G., Park, R.-W., Kim, I.-S., Jeong, S. Y., Kim, K., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.013 · Cited by 460
Self-citationTarget-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels
Lee, H., Mok, H., Lee, S., Oh, Y.-K., & Park, T. G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.011 · Cited by 365
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
Kim, J.-H., Kim, Y.-S., Park, K., Lee, S., Nam, H. Y., Min, K. H., Jo, H. G., Park, J. H., Choi, K., Jeong, S. Y., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.014 · Cited by 350
Self-citationHeparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective
Götte, M., & Yip, G. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1464 · Cited by 340
Eliaz, R. E., & Szoka, F. C. (2001) · PubMed · Cited by 330
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel
Kim, J.-H., Kim, Y.-S., Kim, S., Park, J. H., Kim, K., Choi, K., Chung, H., Jeong, S. Y., Park, R.-W., Kim, I.-S., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.013 · Cited by 313
Self-citationSynthesis and Selective Cytotoxicity of a Hyaluronic Acid−Antitumor Bioconjugate
Luo, Y., & Prestwich, G. D. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9900338 · Cited by 305
Hyaluronic Acid−Paclitaxel Conjugate Micelles: Synthesis, Characterization, and Antitumor Activity
Lee, H., Lee, K., & Park, T. G. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000485 · Cited by 266
Identification of the Hyaluronan Receptor for Endocytosis (HARE)
Zhou, B., Weigel, J. A., Fauss, L., & Weigel, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003030200 · Cited by 265
Park, K., Kim, J.-H., Nam, Y. S., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Kim, I.-S., Choi, K., Kim, S. Y., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.009 · Cited by 257
Self-citationPeer, D., & Margalit, R. (2004) · International Journal of Cancer · doi:10.1002/ijc.11615 · Cited by 229
Ferrari, M. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.46 · Cited by 217
Functionalized Derivatives of Hyaluronic Acid Oligosaccharides: Drug Carriers and Novel Biomaterials
Pouyani, T., & Prestwich, G. D. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00028a010 · Cited by 216
Nanocarriers shape up for long life
Nishiyama, N. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.88 · Cited by 188
Engineering of Biomaterials Surfaces by Hyaluronan
Morra, M. (2005) · Biomacromolecules · doi:10.1021/bm049346i · Cited by 180
Targeted Delivery of Doxorubicin by HPMA Copolymer-Hyaluronan Bioconjugates
Luo, Y., Bernshaw, N. J., Lu, Z.-R., Kopecek, J., & Prestwich, G. D. (2002) · Pharmaceutical Research · doi:10.1023/a:1015170907274 · Cited by 173
Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
Auzenne, E., Ghosh, S. C., Khodadadian, M., Rivera, B., Farquhar, D., Price, R. E., Ravoori, M., Kundra, V., Freedman, R. S., & Klostergaard, J. (2007) · Neoplasia · doi:10.1593/neo.07229 · Cited by 159
Eliaz, R. E., Nir, S., Marty, C., & Szoka, F. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0654 · Cited by 154
Coradini, D., Zorzet, S., Rossin, R., Scarlata, I., Pellizzaro, C., Turrin, C., Bello, M., Cantoni, S., Speranza, A., Sava, G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0349 · Cited by 85
Cited by
Schanté, C. E., Zuber, G., Herlin, C., & Vandamme, T. F. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.03.019 · Cited by 708
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
Mattheolabakis, G., Milane, L., Singh, A., & Amiji, M. M. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1052072 · Cited by 597
Self-assembled hyaluronic acid nanoparticles for active tumor targeting
Choi, K. Y., Chung, H., Min, K. H., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.030 · Cited by 578
Self-citationBiodegradable Polymer Nanogels for Drug/Nucleic Acid Delivery
Li, Y., Maciel, D., Rodrigues, J., Shi, X., & Tomás, H. (2015) · Chemical Reviews · doi:10.1021/cr500131f · Cited by 478
Li, J., Huo, M., Wang, J., Zhou, J., Mohammad, J. M., Zhang, Y., Zhu, Q., Waddad, A. Y., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.022 · Cited by 468
Metadata
- Authors
- Choi, K. Y., Min, K. H., Na, J. H., Choi, K., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y.
- Venue
- Journal of Materials Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2009
- Volume
- 19
- Issue
- 24
- Pages
- 4102
- ISSN
- 0959-9428 (ISSN-L)
- 1364-5501
- OpenAlex
- W2103914087
- Cited by
- 272
- References
- 32
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.